Pablo Gajate (P Gajate)

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 10

Top Topics

Prostate Cancer

Neuroendocrine Tumors

Small Cell Lung Cancer

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Case reports in oncological medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Jorge Esteban-Villarrubia, Javier Torres-Jiménez, Carolina Bueno-Bravo, Rebeca García-Mondaray, José Daniel Subiela, Pablo Gajate
Current and Future Landscape of Perioperative Treatment for Muscle-Invasive Bladder Cancer. Cancers 15 (3) (2023)
Nataliya Mar, Yousef Zakharia, Alejandro Falcon, Rafael Morales-Barrera, Begona Mellado, Ignacio Duran, Do-Youn Oh, Stephen K Williamson, Pablo Gajate, Hendrick-Tobias Arkenau, Robert J Jones, Min Yuen Teo, Tolga Turan, Robert T McLaughlin, Hillary M Peltier, Elizabeth Chong, Harisha Atluri, James P Dean, Daniel Castellano
Results from a Phase 1b/2 Study of Ibrutinib Combination Therapy in Advanced Urothelial Carcinoma. Cancers 15 (11) (2023)
Jorge Esteban-Villarrubia, Javier Torres-Jiménez, Carolina Bueno-Bravo, Rebeca García-Mondaray, José Daniel Subiela, Pablo Gajate
Current and Future Landscape of Perioperative Treatment for Muscle-Invasive Bladder Cancer. Cancers 15 (3) (2023)
Fernando López-Campos, Pablo Gajate, Nuria Romero-Laorden, Juan Zafra Martín, Manel Juan, Susana Hernando Polo, Antonio José Conde-Moreno, Felipe Couñago
Immunotherapy in Advanced Prostate Cancer: Current Knowledge and Future Directions. Biomedicines 10 (3) (2022)
Jaume Capdevila, Arkadiy Klochikhin, Sophie Leboulleux, Pavel Isaev, Corin Badiu, Bruce Robinson, Brett G M Hughes, Bhumsuk Keam, Francis Parnis, Rossella Elisei, Pablo Gajate, Hui K Gan, Ellen Kapiteijn, Laura Locati, Milan Mangeshkar, Leonardo Faoro, Jolanta Krajewska, Barbara Jarzab
A Randomized, Double-Blind Noninferiority Study to Evaluate the Efficacy of the Cabozantinib Tablet at 60 mg Per Day Compared with the Cabozantinib Capsule at 140 mg Per Day in Patients with Progressive, Metastatic Medullary Thyroid Cancer. Thyroid : official journal of the American Thyroid Association 32 (5) (2022)
Víctor Albarrán Fernández, Diana Isabel Rosero, Jesús Chamorro, Javier Pozas, María San Román-Gil, Ana María Barrill, Víctor Alía, Pilar Sotoca, Patricia Guerrero, Juan Carlos Calvo, Inmaculada Orejana, Patricia Pérez de Aguado, Pablo Gajate
Her-2 Targeted Therapy in Advanced Urothelial Cancer: From Monoclonal Antibodies to Antibody-Drug Conjugates. International journal of molecular sciences 23 (20) (2022)
Víctor Albarrán Fernández, Javier Pozas, Juan José Soto Castillo, Jorge Esteban, Elena Corral de la Fuente, Yolanda Lage Alfranca, Pablo Gajate, Pilar Garrido Lopez
Management of Intracranial Metastases in EGFR-Mutated NSCLC: A Review of Literature following an Unusual Case Report. Case reports in oncological medicine 2021 (2021)
Jaume Capdevila, Nicola Fazio, Carlos Lopez, Alexandre Teulé, Juan W Valle, Salvatore Tafuto, Ana Custodio, Nicholas Reed, Markus Raderer, Enrique Grande, Rocio Garcia-Carbonero, Paula Jiménez-Fonseca, Jorge Hernando, Alberto Bongiovanni, Francesca Spada, Vicente Alonso, Lorenzo Antonuzzo, Andrea Spallanzani, Alfredo Berruti, Adelaida La Casta, Isabel Sevilla, Patrizia Kump, Dario Giuffrida, Xavier Merino, Lorena Trejo, Pablo Gajate, Ignacio Matos, Angela Lamarca, Toni Ibrahim
Lenvatinib in Patients With Advanced Grade 1/2 Pancreatic and Gastrointestinal Neuroendocrine Tumors: Results of the Phase II TALENT Trial (GETNE1509). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (20) (2021)
Ivan Marquez-Rodas, Federico Longo, Maria E Rodríguez-Ruiz, Antonio Calles, Santiago Ponce-Aix, Maria Jove, Belén Rubio-Viqueira, Jose Luis Perez-Gracia, Ana Gómez-Rueda, Miguel Martín, Mariano Ponz-Sarvisé, Rosa Álvarez, Ainara Soria-Rivas, Enrique de Miguel, Rocío Ramos-Medina, Eduardo Castañon, Pablo Gajate, Cayetano Sempere Ortega, Elisabeth Jiménez-Aguilar, Maria Angela Aznar, Aitana Calvo, Pedro P López-Casas, Salvador Martín-Algarra, Miguel Martín, Dominique Tersago, Marisol Quintero, Ignacio Melero
Intratumoral nanoplexed poly I:C BO-112 in combination with systemic anti-PD-1 for patients with anti-PD-1-refractory tumors. Science translational medicine 12 (565) (2021)
Pablo Gajate, T Alonso-Gordoa, O Martínez-Sáez, J Molina-Cerrillo, E Grande
Prognostic and predictive role of the PI3K-AKT-mTOR pathway in neuroendocrine neoplasms. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20 (5) (2017)